Pharmacy and Poisons Board: Applications

Protocol No.	Study Title	Principal Investigator(s)	Name of Site / County	Pages	Clear
Application Submission Dates-to- clear!

#	Protocol No	Study Title	Investigator(s) & Site(s)
6.	ECCT/25/01/01	Laborum Doloribus illo impedi Laborum Doloribus illo impedi	Principal Investigator(s) 1. Aidan Madden Yeo Christensen Nola Nielsen Site(s) in Kenya 1. Isadora Long (Vihiga county)	View
7.	ECCT/24/12/01	Et eius sit aut et fugiat adi sample	Principal Investigator(s) 1. Lawrence Jennings Aladdin Powers Elton Delgado Site(s) in Kenya 1. Chastity Horne (Samburu county)	View
8.	ECCT/24/11/02	Iusto obcaecati Nam dicta veli Clinical trials are research studies conducted with human participants to evaluate the safety, effectiveness, and potential side effects of medical interventions, such as new drugs, devices, or therapies. These trials are essential for advancing medical knowledge and ensuring treatments meet rigorous standards. By following a structured approach, clinical trials provide a systematic way to assess new interventions before they are widely adopted in healthcare. The process of clinical trials typically progresses through multiple phases. Early phases focus on determining safety and optimal dosing in smaller groups, while later phases assess the efficacy and broader application of the intervention in larger populations. This phased approach ensures that each stage addresses specific scientific and medical questions, gradually building a comprehensive understanding of the intervention's impact. Ethical guidelines and scientific rigor are crucial in clinical trials to protect participants and maintain public trust. Researchers adhere to principles like informed consent and beneficence while ensuring trials are inclusive and unbiased. By bridging the gap between laboratory research and real-world medical practice, clinical trials play a critical role in improving healthcare outcomes globally.	Principal Investigator(s) 1. Linus Sexton Ori Hill Jacob Mckay Site(s) in Kenya 1.	View
9.	ECCT/24/11/01	Testronimal Study Phase 2 Testronimal Study Phase 2	Principal Investigator(s) 1. Joel Investigator Site(s) in Kenya 1. (Kisumu county)	View
10.	ECCT/24/10/02	user abstract 123	Principal Investigator(s) 1. Irene Peterson Melinda Farrell Marah Bush Site(s) in Kenya 1. Harriet Battle (Kirinyaga county)	View

History
+
Request History
4 previous requests available
====
Session
+
Session
- Config(array)
  userAgent9c3d2c89526db53b7b69e8c9faa06145
  time1756505854
  countdown10
====
Request
+
Request

Cake Params
- plugin(null)
- controllerapplications
- actionindex
- named(array)
  sortprotocol_no
  directiondesc
  page2
- pass(empty)
- isAjax(false)
- paging(array)
  Application(array)
  page2
  current5
  count22
  prevPage(true)
  nextPage(true)
  pageCount5
  order(array)
  Application.protocol_nodesc
  limit5
  options(array)
  page2
  order(array)
  Application.protocol_nodesc
  sortprotocol_no
  directiondesc
  paramTypenamed
Post data
- Application(empty)
Query string

No querystring data.

Cookie

To view Cookies, add CookieComponent to Controller

Current Route
- keys(array)
  0controller
  1action
- options(empty)
- defaults(array)
  plugin(null)
- template/:controller/:action/*
====

Sql Logs

default

Total Time: 3 ms
Total Queries: 10 queries

Query	Affected	Num. rows	Took (ms)	Actions
SELECT `Application`.`id`, `Application`.`user_id`, `Application`.`application_id`, `Application`.`is_child`, `Application`.`trial_status_id`, `Application`.`total_sites`, `Application`.`abstract_of_study`, `Application`.`study_title`, `Application`.`laymans_summary`, `Application`.`short_title`, `Application`.`protocol_no`, `Application`.`reference_no`, `Application`.`version_no`, `Application`.`date_of_protocol`, `Application`.`study_drug`, `Application`.`disease_condition`, `Application`.`product_type_biologicals`, `Application`.`product_type_proteins`, `Application`.`product_type_immunologicals`, `Application`.`product_type_vaccines`, `Application`.`product_type_hormones`, `Application`.`product_type_toxoid`, `Application`.`product_type_chemical`, `Application`.`product_type_medical_device`, `Application`.`product_type_chemical_name`, `Application`.`product_type_medical_device_name`, `Application`.`comparator`, `Application`.`comparator_name`, `Application`.`comparator_registered`, `Application`.`comparator_countries`, `Application`.`ecct_not_applicable`, `Application`.`ecct_ref_number`, `Application`.`email_address`, `Application`.`applicant_covering_letter`, `Application`.`applicant_protocol`, `Application`.`applicant_patient_information`, `Application`.`applicant_investigators_brochure`, `Application`.`applicant_investigators_cv`, `Application`.`applicant_signed_declaration`, `Application`.`applicant_financial_declaration`, `Application`.`applicant_gmp_certificate`, `Application`.`applicant_indemnity_cover`, `Application`.`applicant_opinion_letter`, `Application`.`applicant_approval_letter`, `Application`.`applicant_statement`, `Application`.`applicant_participating_countries`, `Application`.`applicant_addendum`, `Application`.`applicant_fees`, `Application`.`applicant_complete_form`, `Application`.`applicant_impd`, `Application`.`applicant_prev_data`, `Application`.`applicant_stability_data`, `Application`.`applicant_analysis_cert`, `Application`.`applicant_pictorial_sample`, `Application`.`applicant_gcp_training`, `Application`.`applicant_dsmb_charter`, `Application`.`applicant_detailed_budget`, `Application`.`applicant_indemnity_pi`, `Application`.`applicant_practice_license`, `Application`.`applicant_registration_ctr`, `Application`.`applicant_pan_african`, `Application`.`applicant_hard_copies`, `Application`.`applicant_signed_checklist`, `Application`.`statistical_analysis_plan`, `Application`.`applicant_contractual_agreement`, `Application`.`declaration_applicant`, `Application`.`declaration_date1`, `Application`.`declaration_principal_investigator`, `Application`.`declaration_date2`, `Application`.`placebo_present`, `Application`.`study_objectives`, `Application`.`principal_inclusion_criteria`, `Application`.`principal_exclusion_criteria`, `Application`.`primary_end_points`, `Application`.`scope_diagnosis`, `Application`.`scope_prophylaxis`, `Application`.`scope_therapy`, `Application`.`scope_safety`, `Application`.`scope_efficacy`, `Application`.`scope_pharmacokinetic`, `Application`.`scope_pharmacodynamic`, `Application`.`scope_bioequivalence`, `Application`.`scope_dose_response`, `Application`.`scope_pharmacogenetic`, `Application`.`scope_pharmacogenomic`, `Application`.`scope_pharmacoecomomic`, `Application`.`scope_others`, `Application`.`scope_others_specify`, `Application`.`trial_human_pharmacology`, `Application`.`trial_administration_humans`, `Application`.`trial_bioequivalence_study`, `Application`.`trial_other`, `Application`.`trial_other_specify`, `Application`.`trial_therapeutic_exploratory`, `Application`.`trial_therapeutic_confirmatory`, `Application`.`trial_therapeutic_use`, `Application`.`design_controlled`, `Application`.`site_capacity`, `Application`.`staff_numbers`, `Application`.`other_details_explanation`, `Application`.`other_details_regulatory_notapproved`, `Application`.`other_details_regulatory_approved`, `Application`.`other_details_regulatory_rejected`, `Application`.`other_details_regulatory_halted`, `Application`.`estimated_duration`, `Application`.`design_controlled_randomised`, `Application`.`design_controlled_open`, `Application`.`design_controlled_single_blind`, `Application`.`design_controlled_double_blind`, `Application`.`design_controlled_parallel_group`, `Application`.`design_controlled_cross_over`, `Application`.`design_controlled_other`, `Application`.`design_controlled_specify`, `Application`.`design_controlled_comparator`, `Application`.`design_controlled_other_medicinal`, `Application`.`design_controlled_placebo`, `Application`.`design_controlled_medicinal_other`, `Application`.`design_controlled_medicinal_specify`, `Application`.`single_site_member_state`, `Application`.`location_of_area`, `Application`.`single_site_physical_address`, `Application`.`single_site_contact_person`, `Application`.`single_site_telephone`, `Application`.`multiple_sites_member_state`, `Application`.`multiple_countries`, `Application`.`multiple_member_states`, `Application`.`number_of_sites`, `Application`.`multi_country_list`, `Application`.`data_monitoring_committee`, `Application`.`total_enrolment_per_site`, `Application`.`total_participants_worldwide`, `Application`.`population_less_than_18_years`, `Application`.`population_utero`, `Application`.`population_preterm_newborn`, `Application`.`population_newborn`, `Application`.`population_infant_and_toddler`, `Application`.`population_children`, `Application`.`population_adolescent`, `Application`.`population_above_18`, `Application`.`population_adult`, `Application`.`population_elderly`, `Application`.`gender_female`, `Application`.`gender_male`, `Application`.`subjects_healthy`, `Application`.`subjects_patients`, `Application`.`subjects_vulnerable_populations`, `Application`.`subjects_women_child_bearing`, `Application`.`subjects_women_using_contraception`, `Application`.`subjects_pregnant_women`, `Application`.`subjects_nursing_women`, `Application`.`subjects_emergency_situation`, `Application`.`subjects_incapable_consent`, `Application`.`subjects_specify`, `Application`.`subjects_others`, `Application`.`subjects_others_specify`, `Application`.`investigator1_given_name`, `Application`.`investigator1_middle_name`, `Application`.`investigator1_family_name`, `Application`.`investigator1_qualification`, `Application`.`investigator1_professional_address`, `Application`.`investigator1_telephone`, `Application`.`investigator1_email`, `Application`.`organisations_transferred_`, `Application`.`number_participants`, `Application`.`notification`, `Application`.`approval_date`, `Application`.`submitted`, `Application`.`deleted`, `Application`.`deleted_date`, `Application`.`deactivated`, `Application`.`date_submitted`, `Application`.`unsubmitted`, `Application`.`initial_date_submitted`, `Application`.`admin_stopped`, `Application`.`admin_stopped_reason`, `Application`.`approved`, `Application`.`approved_reason`, `Application`.`approved_date`, `Application`.`final_report`, `Application`.`implication_results`, `Application`.`quantity_imported`, `Application`.`quantity_dispensed`, `Application`.`quantity_destroyed`, `Application`.`quantity_exported`, `Application`.`balance_site`, `Application`.`final_date`, `Application`.`ecitizen_invoice`, `Application`.`modified`, `Application`.`created` FROM `ctr`.`applications` AS `Application` WHERE `Application`.`submitted` = '1' AND `Application`.`approved` = 2 AND `Application`.`deactivated` = '0' AND `Application`.`deleted` = '0' ORDER BY `Application`.`protocol_no` desc LIMIT 5, 5	5	5	2	maybe slow
SELECT `InvestigatorContact`.`id`, `InvestigatorContact`.`application_id`, `InvestigatorContact`.`given_name`, `InvestigatorContact`.`middle_name`, `InvestigatorContact`.`family_name`, `InvestigatorContact`.`qualification`, `InvestigatorContact`.`professional_address`, `InvestigatorContact`.`telephone`, `InvestigatorContact`.`email`, `InvestigatorContact`.`created`, `InvestigatorContact`.`modified` FROM `ctr`.`investigator_contacts` AS `InvestigatorContact` WHERE `InvestigatorContact`.`application_id` IN (127, 125, 121, 124, 120)	5	5	0
SELECT `SiteDetail`.`id`, `SiteDetail`.`application_id`, `SiteDetail`.`county_id`, `SiteDetail`.`site_name`, `SiteDetail`.`physical_address`, `SiteDetail`.`contact_details`, `SiteDetail`.`contact_person`, `SiteDetail`.`site_capacity`, `SiteDetail`.`misc`, `SiteDetail`.`created`, `SiteDetail`.`modified` FROM `ctr`.`site_details` AS `SiteDetail` WHERE `SiteDetail`.`application_id` IN (127, 125, 121, 124, 120)	5	5	1	maybe slow
SELECT `County`.`id`, `County`.`county_name`, `County`.`created`, `County`.`modified` FROM `ctr`.`counties` AS `County` WHERE `County`.`id` = 42	1	1	0
SELECT `County`.`id`, `County`.`county_name`, `County`.`created`, `County`.`modified` FROM `ctr`.`counties` AS `County` WHERE `County`.`id` = 38	1	1	0
SELECT `County`.`id`, `County`.`county_name`, `County`.`created`, `County`.`modified` FROM `ctr`.`counties` AS `County` WHERE `County`.`id` = 20	1	1	0
SELECT `County`.`id`, `County`.`county_name`, `County`.`created`, `County`.`modified` FROM `ctr`.`counties` AS `County` WHERE `County`.`id` = 25	1	1	0
SELECT `Sponsor`.`id`, `Sponsor`.`application_id`, `Sponsor`.`sponsor`, `Sponsor`.`sponsor_type`, `Sponsor`.`contact_person`, `Sponsor`.`address`, `Sponsor`.`telephone_number`, `Sponsor`.`fax_number`, `Sponsor`.`cell_number`, `Sponsor`.`email_address`, `Sponsor`.`created`, `Sponsor`.`modified` FROM `ctr`.`sponsors` AS `Sponsor` WHERE `Sponsor`.`application_id` IN (127, 125, 121, 124, 120)	5	5	0
SELECT COUNT(*) AS `count` FROM `ctr`.`applications` AS `Application` WHERE `Application`.`submitted` = '1' AND `Application`.`approved` = 2 AND `Application`.`deactivated` = '0' AND `Application`.`deleted` = '0'	1	1	0
SELECT `TrialStatus`.`id`, `TrialStatus`.`name` FROM `ctr`.`trial_statuses` AS `TrialStatus` WHERE 1 = 1	11	11	0

Query Explain:

Click an "Explain" link above, to see the query explanation.

====

Timer

Memory

Peak Memory Use 9.70 MB

Message	Memory use
Component initialization	2.40 MB
Controller action start	3.58 MB
Controller render start	4.51 MB
View render complete	5.00 MB

Timers

Total Request Time: 77 (ms)

Message	Time in ms	Graph
Core Processing (Derived from $_SERVER["REQUEST_TIME"])	10.47
Event: Controller.initialize	0.28
Event: Controller.startup	0.55
Controller action	18.93
Event: Controller.beforeRender	17.79
» Processing toolbar data	17.55
Rendering View	8.97
» Event: View.beforeRender	0.03
» Rendering APP/View/Applications/index.ctp	0.19
» » Rendering APP/View/Elements/google-recommend.ctp	0.04
» Rendering APP/View/Elements/application/public_index.ctp	5.98
» Event: View.afterRender	0.02
» Event: View.beforeLayout	0.02
» Rendering APP/View/Layouts/default.ctp	2.16
» » Rendering APP/View/Elements/google-analytics.ctp	0.24
Event: View.afterLayout	0.00

====

Log
+

Logs

There were no log entries made this request

====
Variables
+
View Variables
- trial_statuses(array)
 1Recruiting
 2Not yet recruiting
 3Suspended
 4Stopped
 5Completed
 6In follow-up
 7Analysing
 8Writing-up
 9Application withdrawn
 10Paused or preparation for extension of study
 11Revoked
- applications(array)
 0(array)
 Application(array)
 id127
 user_id26
 application_id(null)
 is_child0
 trial_status_id7
 total_sites3
 abstract_of_study\n test\n
 study_title\n Laborum Doloribus illo impedi\n
 laymans_summary\n test\n
 short_titleLaborum Doloribus illo impedi
 protocol_noECCT/25/01/01
 reference_no
 version_noEt duis deserunt tempor blanditiis omnis cum distinctio
 date_of_protocol15-01-1977
 study_drugOccaecat quidem sunt officia adipisci aperiam reprehenderit illo error culpa atque ut voluptas sit vero
 disease_conditionImpedit eaque facilis dignissimos magni dolorem sit dolore in quia modi cumque dicta
 product_type_biologicals0
 product_type_proteins0
 product_type_immunologicals1
 product_type_vaccines0
 product_type_hormones1
 product_type_toxoid0
 product_type_chemical0
 product_type_medical_device1
 product_type_chemical_nameAmela Wiley
 product_type_medical_device_nameMiranda Fry
 comparatorYes
 comparator_nameHolmes Tanner
 comparator_registeredEnim aperiam incidunt est ut
 comparator_countriesDeserunt eiusmod ver
 ecct_not_applicable0
 ecct_ref_number
 email_addressqimuvo@mailinator.com
 applicant_covering_letter1
 applicant_protocol1
 applicant_patient_information1
 applicant_investigators_brochure1
 applicant_investigators_cv1
 applicant_signed_declaration1
 applicant_financial_declaration1
 applicant_gmp_certificate1
 applicant_indemnity_cover1
 applicant_opinion_letter1
 applicant_approval_letter1
 applicant_statement1
 applicant_participating_countries(null)
 applicant_addendum1
 applicant_fees1
 applicant_complete_form(null)
 applicant_impd1
 applicant_prev_data1
 applicant_stability_data1
 applicant_analysis_cert1
 applicant_pictorial_sample1
 applicant_gcp_training1
 applicant_dsmb_charter1
 applicant_detailed_budget1
 applicant_indemnity_pi1
 applicant_practice_license1
 applicant_registration_ctr(null)
 applicant_pan_african1
 applicant_hard_copies(null)
 applicant_signed_checklist1
 statistical_analysis_plan1
 applicant_contractual_agreement0
 declaration_applicantUnde lorem aut expedita sed assumenda sint qui cupiditate
 declaration_date108-12-2013
 declaration_principal_investigatorError tempor odit dicta aute perferendis autem cum doloribus omnis odio quaerat nihil reiciendis quasi eos minima itaque
 declaration_date207-01-2025
 placebo_presentYes
 study_objectives\n test\n
 principal_inclusion_criteria\n test\n
 principal_exclusion_criteria\n test\n
 primary_end_points\n test\n
 scope_diagnosis1
 scope_prophylaxis0
 scope_therapy1
 scope_safety1
 scope_efficacy0
 scope_pharmacokinetic0
 scope_pharmacodynamic1
 scope_bioequivalence0
 scope_dose_response0
 scope_pharmacogenetic0
 scope_pharmacogenomic1
 scope_pharmacoecomomic0
 scope_others0
 scope_others_specify
 trial_human_pharmacology1
 trial_administration_humans0
 trial_bioequivalence_study1
 trial_other0
 trial_other_specify
 trial_therapeutic_exploratory1
 trial_therapeutic_confirmatory1
 trial_therapeutic_use0
 design_controlledNo
 site_capacity(null)
 staff_numbers\n test\n
 other_details_explanation\n test\n
 other_details_regulatory_notapproved\n tets\n
 other_details_regulatory_approved\n test\n
 other_details_regulatory_rejected\n tets\n
 other_details_regulatory_halted\n test\n
 estimated_durationEx qui assumenda laudantium eos dolor voluptatem Quaerat vero ut ex voluptatem corporis neque laborum Irure
 design_controlled_randomised
 design_controlled_open
 design_controlled_single_blind
 design_controlled_double_blind
 design_controlled_parallel_group
 design_controlled_cross_over
 design_controlled_other
 design_controlled_specify
 design_controlled_comparator
 design_controlled_other_medicinal
 design_controlled_placebo
 design_controlled_medicinal_other
 design_controlled_medicinal_specify
 single_site_member_stateNo
 location_of_area
 single_site_physical_address
 single_site_contact_person
 single_site_telephone
 multiple_sites_member_stateYes
 multiple_countriesYes
 multiple_member_states20
 number_of_sites2
 multi_country_listEos aute voluptatem
 data_monitoring_committeeNo
 total_enrolment_per_site200
 total_participants_worldwideVoluptatem incididunt nostrud sint error nobis itaque nisi enim
 population_less_than_18_yearsYes
 population_uteroNo
 population_preterm_newbornYes
 population_newbornYes
 population_infant_and_toddlerYes
 population_childrenYes
 population_adolescentNo
 population_above_18Yes
 population_adultYes
 population_elderlyNo
 gender_female0
 gender_male1
 subjects_healthyYes
 subjects_patientsNo
 subjects_vulnerable_populationsYes
 subjects_women_child_bearingNo
 subjects_women_using_contraceptionYes
 subjects_pregnant_womenYes
 subjects_nursing_womenUnclear
 subjects_emergency_situationYes
 subjects_incapable_consentYes
 subjects_specifyLabore quae cum qui
 subjects_othersYes
 subjects_others_specifyVoluptate qui sed al
 investigator1_given_nameRemedios Steele
 investigator1_middle_nameTaShya Moore
 investigator1_family_nameBrady Key
 investigator1_qualificationEveniet laudantium doloremque provident illo maiores asperiores animi totam reiciendis corporis est
 investigator1_professional_addressVoluptatibus voluptates nemo sit et lorem
 investigator1_telephone+1 (974) 807-5529
 investigator1_emailcuvicenuwy@mailinator.com
 organisations_transferred_No
 number_participants20000
 notification\n test\n
 approval_date07-01-2025
 submitted1
 deleted0
 deleted_date(null)
 deactivated0
 date_submitted07-01-2025
 unsubmitted1
 initial_date_submitted07-01-2025
 admin_stopped0
 admin_stopped_reason(null)
 approved2
 approved_reasontest
 approved_date(null)
 final_report(null)
 implication_results(null)
 quantity_imported(null)
 quantity_dispensed(null)
 quantity_destroyed(null)
 quantity_exported(null)
 balance_site(null)
 final_date(null)
 ecitizen_invoice343770
 modified2025-02-18 08:53:19
 created2025-01-06 15:07:01
 InvestigatorContact(array)
 0(array)
 id84
 application_id127
 given_nameAidan Madden
 middle_nameYeo Christensen
 family_nameNola Nielsen
 qualificationNecessitatibus sed amet quia mollitia quia magnam nostrum elit vel et repellendus Culpa
 professional_addressConsectetur iure ea blanditiis illo facilis sed magna elit non alias
 telephone+1 (375) 498-2766
 emailtomap@mailinator.com
 created2025-01-06 15:08:18
 modified2025-02-06 14:33:08
 SiteDetail(array)
 0(array)
 id129
 application_id127
 county_id38
 site_nameIsadora Long
 physical_addressQuas aut corporis in ea incidunt eligendi voluptas tempora sed ex et eiusmod illum ipsam quibusdam delectus officia exercitationem velit
 contact_detailsP.O. Box 5
 contact_personAnimi et porro velit excepturi vitae lorem excepturi iusto est labore excepturi ipsa sunt ad beatae velit
 site_capacity(null)
 misc(null)
 created2013-06-27 11:37:16
 modified2025-02-06 14:33:08
 County(array)
 id38
 county_nameVihiga
 created2012-06-15 10:26:37
 modified2012-06-15 10:26:37
 Sponsor(array)
 0(array)
 id34
 application_id127
 sponsorFugit nulla amet numquam veniam qui minim ratione ducimus voluptatem Eos molestiae obcaecati est repudiandae aut id Nam enim ut
 sponsor_typeResearch Institution
 contact_personQuasi voluptas voluptate veritatis quis
 addressVoluptatem Sit eum voluptas nobis aliqua Nostrud minus officia voluptatum eveniet vel lorem aperiam cupidatat
 telephone_number+1 (924) 838-9502
 fax_number+1 (461) 834-7154
 cell_number+1 (976) 269-8435
 email_addressgopokilos@mailinator.com
 created2025-01-06 15:08:18
 modified2025-02-06 14:33:08
 1(array)
 Application(array)
 id125
 user_id29
 application_id(null)
 is_child0
 trial_status_id10
 total_sites5
 abstract_of_study\n sample\n
 study_title\n sample\n
 laymans_summary\n sample\n
 short_titleEt eius sit aut et fugiat adi
 protocol_noECCT/24/12/01
 reference_no(null)
 version_noDolorem veniam pariatur Consequat Numquam et digniss
 date_of_protocol01-12-2024
 study_drugId debitis rerum natus molestiae reprehenderit doloremque recusandae Ratione perspiciatis velit minim delectus similique suscipit fugiat
 disease_conditionTempor numquam voluptas amet aut tempore repellendus Magni pariatur
 product_type_biologicals0
 product_type_proteins0
 product_type_immunologicals1
 product_type_vaccines0
 product_type_hormones1
 product_type_toxoid0
 product_type_chemical0
 product_type_medical_device1
 product_type_chemical_nameStone Atkins
 product_type_medical_device_nameAnthony Lawrence
 comparatorNo
 comparator_nameSydnee Woods
 comparator_registeredEt sint officia eos asperiore
 comparator_countriesVel anim voluptatem
 ecct_not_applicable0
 ecct_ref_number
 email_addressjkiprotich@intellisoftkenya.com
 applicant_covering_letter1
 applicant_protocol1
 applicant_patient_information1
 applicant_investigators_brochure1
 applicant_investigators_cv1
 applicant_signed_declaration1
 applicant_financial_declaration1
 applicant_gmp_certificate1
 applicant_indemnity_cover1
 applicant_opinion_letter1
 applicant_approval_letter1
 applicant_statement1
 applicant_participating_countries(null)
 applicant_addendum1
 applicant_fees1
 applicant_complete_form(null)
 applicant_impd1
 applicant_prev_data1
 applicant_stability_data1
 applicant_analysis_cert1
 applicant_pictorial_sample1
 applicant_gcp_training1
 applicant_dsmb_charter1
 applicant_detailed_budget1
 applicant_indemnity_pi1
 applicant_practice_license1
 applicant_registration_ctr(null)
 applicant_pan_african1
 applicant_hard_copies(null)
 applicant_signed_checklist1
 statistical_analysis_plan1
 applicant_contractual_agreement1
 declaration_applicantQuo tenetur ex ut tempora consequatur rerum qui amet officiis sed molestiae fuga Quibusdam velit eu soluta voluptates amet
 declaration_date117-12-2024
 declaration_principal_investigatorSint explicabo Sint quos omnis quia aliquid non ullamco ipsum quia dignissimos qui et consequat Voluptatum cupidatat aut
 declaration_date217-12-2024
 placebo_presentYes
 study_objectives\n sample\n
 principal_inclusion_criteria\n sample\n
 principal_exclusion_criteria\n sample\n
 primary_end_points\n sample\n
 scope_diagnosis1
 scope_prophylaxis0
 scope_therapy0
 scope_safety1
 scope_efficacy0
 scope_pharmacokinetic0
 scope_pharmacodynamic1
 scope_bioequivalence0
 scope_dose_response0
 scope_pharmacogenetic0
 scope_pharmacogenomic1
 scope_pharmacoecomomic0
 scope_others0
 scope_others_specify
 trial_human_pharmacology0
 trial_administration_humans0
 trial_bioequivalence_study1
 trial_other0
 trial_other_specify
 trial_therapeutic_exploratory1
 trial_therapeutic_confirmatory0
 trial_therapeutic_use0
 design_controlledYes
 site_capacity(null)
 staff_numbers\n sample\n
 other_details_explanation\n sample\n
 other_details_regulatory_notapproved\n sample\n
 other_details_regulatory_approved\n sample\n
 other_details_regulatory_rejected\n sample\n
 other_details_regulatory_halted\n sample\n
 estimated_duration4
 design_controlled_randomisedNo
 design_controlled_openYes
 design_controlled_single_blindNo
 design_controlled_double_blindNo
 design_controlled_parallel_groupYes
 design_controlled_cross_overYes
 design_controlled_otherNo
 design_controlled_specify
 design_controlled_comparatorRecusandae Fuga Ut est
 design_controlled_other_medicinalYes
 design_controlled_placeboYes
 design_controlled_medicinal_otherNo
 design_controlled_medicinal_specify
 single_site_member_stateNo
 location_of_area
 single_site_physical_address
 single_site_contact_person
 single_site_telephone
 multiple_sites_member_stateYes
 multiple_countriesNo
 multiple_member_states
 number_of_sites543
 multi_country_list
 data_monitoring_committeeYes
 total_enrolment_per_siteQuidem in duis fugia
 total_participants_worldwideSit ut quae amet at tempor et commodo voluptas quod neque adipisci nemo labore Nam officia ut commodi
 population_less_than_18_yearsYes
 population_uteroNo
 population_preterm_newbornNo
 population_newbornNo
 population_infant_and_toddlerNo
 population_childrenNo
 population_adolescentYes
 population_above_18Yes
 population_adultNo
 population_elderlyNo
 gender_female1
 gender_male0
 subjects_healthyYes
 subjects_patientsYes
 subjects_vulnerable_populationsYes
 subjects_women_child_bearingYes
 subjects_women_using_contraceptionNo
 subjects_pregnant_womenNo
 subjects_nursing_womenYes
 subjects_emergency_situationYes
 subjects_incapable_consentYes
 subjects_specifyFacilis quia totam u
 subjects_othersYes
 subjects_others_specifyNulla ipsam dolore i
 investigator1_given_nameDominique Solomon
 investigator1_middle_nameHyacinth Bond
 investigator1_family_nameIndira Shaffer
 investigator1_qualificationRerum adipisicing magnam qui rerum nemo dicta eligendi quis inventore provident accusantium aperiam ipsum enim qui asperiores
 investigator1_professional_addressSit aut at tenetur enim culpa
 investigator1_telephone+1 (956) 653-5189
 investigator1_emailpydekizef@mailinator.com
 organisations_transferred_Yes
 number_participantsVoluptatum aliqua I
 notification\n sample\n
 approval_date17-12-2024
 submitted1
 deleted0
 deleted_date(null)
 deactivated0
 date_submitted17-12-2024
 unsubmitted1
 initial_date_submitted17-12-2024
 admin_stopped0
 admin_stopped_reason(null)
 approved2
 approved_reason
 approved_date(null)
 final_report(null)
 implication_results(null)
 quantity_imported(null)
 quantity_dispensed(null)
 quantity_destroyed(null)
 quantity_exported(null)
 balance_site(null)
 final_date(null)
 ecitizen_invoice(null)
 modified2025-01-07 08:39:12
 created2024-11-29 09:22:21
 InvestigatorContact(array)
 0(array)
 id81
 application_id125
 given_nameLawrence Jennings
 middle_nameAladdin Powers
 family_nameElton Delgado
 qualificationUllam deleniti aliqua Excepteur nisi id dolorum vel ipsum a irure repudiandae molestias aut quos suscipit et dolore reprehenderit eu
 professional_addressUt facere ea aliquam eveniet
 telephone+1 (328) 771-3449
 emailxycuqez@mailinator.com
 created2024-12-17 08:32:23
 modified2025-01-06 11:48:30
 SiteDetail(array)
 0(array)
 id1705
 application_id125
 county_id25
 site_nameChastity Horne
 physical_addressA alias veritatis aute asperiores voluptatem anim id irure veniam qui
 contact_detailsPO Box 91937
 contact_personAtque esse sint consectetur qui tempor dicta sit illo id consectetur illo qui quo soluta
 site_capacity(null)
 misc(null)
 created2024-12-17 08:32:23
 modified2025-01-06 11:48:30
 County(array)
 id25
 county_nameSamburu
 created2012-06-15 10:24:58
 modified2012-06-15 10:24:58
 Sponsor(array)
 0(array)
 id33
 application_id125
 sponsorDolore sunt reprehenderit voluptas commodi asperiores
 sponsor_typeIndustry
 contact_personAd consequatur nulla aut quo explicabo Eligendi similique ex cum sed voluptas sint sit dolorem nulla asperiores suscipit
 addressQuis ipsa voluptatum non officia nisi minus officia est et
 telephone_number+1 (498) 749-6935
 fax_number+1 (547) 888-9241
 cell_number+1 (941) 425-9332
 email_addresscidesy@mailinator.com
 created2024-12-17 08:32:23
 modified2025-01-06 11:48:30
 2(array)
 Application(array)
 id121
 user_id29
 application_id(null)
 is_child0
 trial_status_id10
 total_sites4
 abstract_of_study\n Clinical trials are research studies conducted with human participants to evaluate the safety, effectiveness, and potential side effects of medical interventions, such as new drugs, devices, or therapies. These trials are essential for advancing medical knowledge and ensuring treatments meet rigorous standards. By following a structured approach, clinical trials provide a systematic way to assess new interventions before they are widely adopted in healthcare.\n\n The process of clinical trials typically progresses through multiple phases. Early phases focus on determining safety and optimal dosing in smaller groups, while later phases assess the efficacy and broader application of the intervention in larger populations. This phased approach ensures that each stage addresses specific scientific and medical questions, gradually building a comprehensive understanding of the intervention's impact.\n\n Ethical guidelines and scientific rigor are crucial in clinical trials to protect participants and maintain public trust. Researchers adhere to principles like informed consent and beneficence while ensuring trials are inclusive and unbiased. By bridging the gap between laboratory research and real-world medical practice, clinical trials play a critical role in improving healthcare outcomes globally.\n
 study_title\n Clinical trials are research studies conducted with human participants to evaluate the safety, effectiveness, and potential side effects of medical interventions, such as new drugs, devices, or therapies. These trials are essential for advancing medical knowledge and ensuring treatments meet rigorous standards. By following a structured approach, clinical trials provide a systematic way to assess new interventions before they are widely adopted in healthcare.\n\n The process of clinical trials typically progresses through multiple phases. Early phases focus on determining safety and optimal dosing in smaller groups, while later phases assess the efficacy and broader application of the intervention in larger populations. This phased approach ensures that each stage addresses specific scientific and medical questions, gradually building a comprehensive understanding of the intervention's impact.\n\n Ethical guidelines and scientific rigor are crucial in clinical trials to protect participants and maintain public trust. Researchers adhere to principles like informed consent and beneficence while ensuring trials are inclusive and unbiased. By bridging the gap between laboratory research and real-world medical practice, clinical trials play a critical role in improving healthcare outcomes globally.\n
 laymans_summary\n Clinical trials are research studies conducted with human participants to evaluate the safety, effectiveness, and potential side effects of medical interventions, such as new drugs, devices, or therapies. These trials are essential for advancing medical knowledge and ensuring treatments meet rigorous standards. By following a structured approach, clinical trials provide a systematic way to assess new interventions before they are widely adopted in healthcare.\n\n The process of clinical trials typically progresses through multiple phases. Early phases focus on determining safety and optimal dosing in smaller groups, while later phases assess the efficacy and broader application of the intervention in larger populations. This phased approach ensures that each stage addresses specific scientific and medical questions, gradually building a comprehensive understanding of the intervention's impact.\n\n Ethical guidelines and scientific rigor are crucial in clinical trials to protect participants and maintain public trust. Researchers adhere to principles like informed consent and beneficence while ensuring trials are inclusive and unbiased. By bridging the gap between laboratory research and real-world medical practice, clinical trials play a critical role in improving healthcare outcomes globally.\n
 short_titleIusto obcaecati Nam dicta veli
 protocol_noECCT/24/11/02
 reference_no(null)
 version_noConsectetur qui ipsam omnis eos et voluptas
 date_of_protocol20-11-2015
 study_drugEst esse ex reprehenderit aute laborum illo consectetur soluta atque dolor quia numquam odit delectus et aut placeat
 disease_conditionEt officia qui consequuntur quisquam veritatis obcaecati sunt non sit dolorum quae
 product_type_biologicals0
 product_type_proteins1
 product_type_immunologicals1
 product_type_vaccines0
 product_type_hormones0
 product_type_toxoid1
 product_type_chemical1
 product_type_medical_device1
 product_type_chemical_nameEagan Alston
 product_type_medical_device_nameTanisha Rowland
 comparatorYes
 comparator_nameBrendan Blair
 comparator_registeredAut enim quaerat consequatur s
 comparator_countriesRerum quis ut veniam
 ecct_not_applicable0
 ecct_ref_number
 email_addressjkiprotich@intellisoftkenya.com
 applicant_covering_letter1
 applicant_protocol1
 applicant_patient_information1
 applicant_investigators_brochure1
 applicant_investigators_cv1
 applicant_signed_declaration1
 applicant_financial_declaration1
 applicant_gmp_certificate1
 applicant_indemnity_cover1
 applicant_opinion_letter1
 applicant_approval_letter1
 applicant_statement1
 applicant_participating_countries(null)
 applicant_addendum1
 applicant_fees1
 applicant_complete_form(null)
 applicant_impd1
 applicant_prev_data1
 applicant_stability_data1
 applicant_analysis_cert1
 applicant_pictorial_sample1
 applicant_gcp_training1
 applicant_dsmb_charter1
 applicant_detailed_budget1
 applicant_indemnity_pi1
 applicant_practice_license1
 applicant_registration_ctr(null)
 applicant_pan_african1
 applicant_hard_copies(null)
 applicant_signed_checklist1
 statistical_analysis_plan1
 applicant_contractual_agreement1
 declaration_applicantSunt atque ipsum obcaecati commodo aspernatur fuga Voluptatem sed sequi cupidatat quo enim
 declaration_date107-11-2024
 declaration_principal_investigatorSit reprehenderit dicta beatae officia et magni deserunt ipsum in sint voluptates sed necessitatibus neque quis aspernatur esse ut
 declaration_date214-11-2024
 placebo_presentYes
 study_objectives\n Clinical trials are research studies conducted with human participants to evaluate the safety, effectiveness, and potential side effects of medical interventions, such as new drugs, devices, or therapies. These trials are essential for advancing medical knowledge and ensuring treatments meet rigorous standards. By following a structured approach, clinical trials provide a systematic way to assess new interventions before they are widely adopted in healthcare.\n\n The process of clinical trials typically progresses through multiple phases. Early phases focus on determining safety and optimal dosing in smaller groups, while later phases assess the efficacy and broader application of the intervention in larger populations. This phased approach ensures that each stage addresses specific scientific and medical questions, gradually building a comprehensive understanding of the intervention's impact.\n\n Ethical guidelines and scientific rigor are crucial in clinical trials to protect participants and maintain public trust. Researchers adhere to principles like informed consent and beneficence while ensuring trials are inclusive and unbiased. By bridging the gap between laboratory research and real-world medical practice, clinical trials play a critical role in improving healthcare outcomes globally.\n
 principal_inclusion_criteria\n Clinical trials are research studies conducted with human participants to evaluate the safety, effectiveness, and potential side effects of medical interventions, such as new drugs, devices, or therapies. These trials are essential for advancing medical knowledge and ensuring treatments meet rigorous standards. By following a structured approach, clinical trials provide a systematic way to assess new interventions before they are widely adopted in healthcare.\n\n The process of clinical trials typically progresses through multiple phases. Early phases focus on determining safety and optimal dosing in smaller groups, while later phases assess the efficacy and broader application of the intervention in larger populations. This phased approach ensures that each stage addresses specific scientific and medical questions, gradually building a comprehensive understanding of the intervention's impact.\n\n Ethical guidelines and scientific rigor are crucial in clinical trials to protect participants and maintain public trust. Researchers adhere to principles like informed consent and beneficence while ensuring trials are inclusive and unbiased. By bridging the gap between laboratory research and real-world medical practice, clinical trials play a critical role in improving healthcare outcomes globally.\n
 principal_exclusion_criteria\n Clinical trials are research studies conducted with human participants to evaluate the safety, effectiveness, and potential side effects of medical interventions, such as new drugs, devices, or therapies. These trials are essential for advancing medical knowledge and ensuring treatments meet rigorous standards. By following a structured approach, clinical trials provide a systematic way to assess new interventions before they are widely adopted in healthcare.\n\n The process of clinical trials typically progresses through multiple phases. Early phases focus on determining safety and optimal dosing in smaller groups, while later phases assess the efficacy and broader application of the intervention in larger populations. This phased approach ensures that each stage addresses specific scientific and medical questions, gradually building a comprehensive understanding of the intervention's impact.\n\n Ethical guidelines and scientific rigor are crucial in clinical trials to protect participants and maintain public trust. Researchers adhere to principles like informed consent and beneficence while ensuring trials are inclusive and unbiased. By bridging the gap between laboratory research and real-world medical practice, clinical trials play a critical role in improving healthcare outcomes globally.\n
 primary_end_points\n Clinical trials are research studies conducted with human participants to evaluate the safety, effectiveness, and potential side effects of medical interventions, such as new drugs, devices, or therapies. These trials are essential for advancing medical knowledge and ensuring treatments meet rigorous standards. By following a structured approach, clinical trials provide a systematic way to assess new interventions before they are widely adopted in healthcare.\n\n The process of clinical trials typically progresses through multiple phases. Early phases focus on determining safety and optimal dosing in smaller groups, while later phases assess the efficacy and broader application of the intervention in larger populations. This phased approach ensures that each stage addresses specific scientific and medical questions, gradually building a comprehensive understanding of the intervention's impact.\n\n Ethical guidelines and scientific rigor are crucial in clinical trials to protect participants and maintain public trust. Researchers adhere to principles like informed consent and beneficence while ensuring trials are inclusive and unbiased. By bridging the gap between laboratory research and real-world medical practice, clinical trials play a critical role in improving healthcare outcomes globally.\n
 scope_diagnosis1
 scope_prophylaxis1
 scope_therapy1
 scope_safety0
 scope_efficacy1
 scope_pharmacokinetic0
 scope_pharmacodynamic0
 scope_bioequivalence0
 scope_dose_response0
 scope_pharmacogenetic0
 scope_pharmacogenomic1
 scope_pharmacoecomomic0
 scope_others1
 scope_others_specifyLorem voluptatem Ab
 trial_human_pharmacology1
 trial_administration_humans1
 trial_bioequivalence_study1
 trial_other1
 trial_other_specifySimilique tempore c
 trial_therapeutic_exploratory1
 trial_therapeutic_confirmatory1
 trial_therapeutic_use1
 design_controlledYes
 site_capacity(null)
 staff_numbers\n Clinical trials are research studies conducted with human participants to evaluate the safety, effectiveness, and potential side effects of medical interventions, such as new drugs, devices, or therapies. These trials are essential for advancing medical knowledge and ensuring treatments meet rigorous standards. By following a structured approach, clinical trials provide a systematic way to assess new interventions before they are widely adopted in healthcare.\n\n The process of clinical trials typically progresses through multiple phases. Early phases focus on determining safety and optimal dosing in smaller groups, while later phases assess the efficacy and broader application of the intervention in larger populations. This phased approach ensures that each stage addresses specific scientific and medical questions, gradually building a comprehensive understanding of the intervention's impact.\n\n Ethical guidelines and scientific rigor are crucial in clinical trials to protect participants and maintain public trust. Researchers adhere to principles like informed consent and beneficence while ensuring trials are inclusive and unbiased. By bridging the gap between laboratory research and real-world medical practice, clinical trials play a critical role in improving healthcare outcomes globally.\n
 other_details_explanation\n Clinical trials are research studies conducted with human participants to evaluate the safety, effectiveness, and potential side effects of medical interventions, such as new drugs, devices, or therapies. These trials are essential for advancing medical knowledge and ensuring treatments meet rigorous standards. By following a structured approach, clinical trials provide a systematic way to assess new interventions before they are widely adopted in healthcare.\n\n The process of clinical trials typically progresses through multiple phases. Early phases focus on determining safety and optimal dosing in smaller groups, while later phases assess the efficacy and broader application of the intervention in larger populations. This phased approach ensures that each stage addresses specific scientific and medical questions, gradually building a comprehensive understanding of the intervention's impact.\n\n Ethical guidelines and scientific rigor are crucial in clinical trials to protect participants and maintain public trust. Researchers adhere to principles like informed consent and beneficence while ensuring trials are inclusive and unbiased. By bridging the gap between laboratory research and real-world medical practice, clinical trials play a critical role in improving healthcare outcomes globally.\n
 other_details_regulatory_notapproved\n Clinical trials are research studies conducted with human participants to evaluate the safety, effectiveness, and potential side effects of medical interventions, such as new drugs, devices, or therapies. These trials are essential for advancing medical knowledge and ensuring treatments meet rigorous standards. By following a structured approach, clinical trials provide a systematic way to assess new interventions before they are widely adopted in healthcare.\n\n The process of clinical trials typically progresses through multiple phases. Early phases focus on determining safety and optimal dosing in smaller groups, while later phases assess the efficacy and broader application of the intervention in larger populations. This phased approach ensures that each stage addresses specific scientific and medical questions, gradually building a comprehensive understanding of the intervention's impact.\n\n Ethical guidelines and scientific rigor are crucial in clinical trials to protect participants and maintain public trust. Researchers adhere to principles like informed consent and beneficence while ensuring trials are inclusive and unbiased. By bridging the gap between laboratory research and real-world medical practice, clinical trials play a critical role in improving healthcare outcomes globally.\n
 other_details_regulatory_approved\n Clinical trials are research studies conducted with human participants to evaluate the safety, effectiveness, and potential side effects of medical interventions, such as new drugs, devices, or therapies. These trials are essential for advancing medical knowledge and ensuring treatments meet rigorous standards. By following a structured approach, clinical trials provide a systematic way to assess new interventions before they are widely adopted in healthcare.\n\n The process of clinical trials typically progresses through multiple phases. Early phases focus on determining safety and optimal dosing in smaller groups, while later phases assess the efficacy and broader application of the intervention in larger populations. This phased approach ensures that each stage addresses specific scientific and medical questions, gradually building a comprehensive understanding of the intervention's impact.\n\n Ethical guidelines and scientific rigor are crucial in clinical trials to protect participants and maintain public trust. Researchers adhere to principles like informed consent and beneficence while ensuring trials are inclusive and unbiased. By bridging the gap between laboratory research and real-world medical practice, clinical trials play a critical role in improving healthcare outcomes globally.\n
 other_details_regulatory_rejected\n Clinical trials are research studies conducted with human participants to evaluate the safety, effectiveness, and potential side effects of medical interventions, such as new drugs, devices, or therapies. These trials are essential for advancing medical knowledge and ensuring treatments meet rigorous standards. By following a structured approach, clinical trials provide a systematic way to assess new interventions before they are widely adopted in healthcare.\n\n The process of clinical trials typically progresses through multiple phases. Early phases focus on determining safety and optimal dosing in smaller groups, while later phases assess the efficacy and broader application of the intervention in larger populations. This phased approach ensures that each stage addresses specific scientific and medical questions, gradually building a comprehensive understanding of the intervention's impact.\n\n Ethical guidelines and scientific rigor are crucial in clinical trials to protect participants and maintain public trust. Researchers adhere to principles like informed consent and beneficence while ensuring trials are inclusive and unbiased. By bridging the gap between laboratory research and real-world medical practice, clinical trials play a critical role in improving healthcare outcomes globally.\n
 other_details_regulatory_halted\n Clinical trials are research studies conducted with human participants to evaluate the safety, effectiveness, and potential side effects of medical interventions, such as new drugs, devices, or therapies. These trials are essential for advancing medical knowledge and ensuring treatments meet rigorous standards. By following a structured approach, clinical trials provide a systematic way to assess new interventions before they are widely adopted in healthcare.\n\n The process of clinical trials typically progresses through multiple phases. Early phases focus on determining safety and optimal dosing in smaller groups, while later phases assess the efficacy and broader application of the intervention in larger populations. This phased approach ensures that each stage addresses specific scientific and medical questions, gradually building a comprehensive understanding of the intervention's impact.\n\n Ethical guidelines and scientific rigor are crucial in clinical trials to protect participants and maintain public trust. Researchers adhere to principles like informed consent and beneficence while ensuring trials are inclusive and unbiased. By bridging the gap between laboratory research and real-world medical practice, clinical trials play a critical role in improving healthcare outcomes globally.\n
 estimated_duration3
 design_controlled_randomisedNo
 design_controlled_openNo
 design_controlled_single_blindYes
 design_controlled_double_blindNo
 design_controlled_parallel_groupYes
 design_controlled_cross_overNo
 design_controlled_otherYes
 design_controlled_specifyEum labore saepe rem quia sint dolore porro magni nihil facilis doloribus sint ipsa et officia distinctio Aut
 design_controlled_comparatorBlanditiis quaerat est ex
 design_controlled_other_medicinalYes
 design_controlled_placeboNo
 design_controlled_medicinal_otherNo
 design_controlled_medicinal_specify
 single_site_member_stateNo
 location_of_area
 single_site_physical_address
 single_site_contact_person
 single_site_telephone
 multiple_sites_member_stateNo
 multiple_countriesYes
 multiple_member_states4
 number_of_sites
 multi_country_listHarum hic tempora ne
 data_monitoring_committeeYes
 total_enrolment_per_siteNon ex beatae a dele
 total_participants_worldwideExcepteur maxime nisi voluptatem minim ad quisquam harum dolore doloribus quia sunt consequatur Perspiciatis doloribus sed
 population_less_than_18_yearsYes
 population_uteroNo
 population_preterm_newbornYes
 population_newbornYes
 population_infant_and_toddlerNo
 population_childrenNo
 population_adolescentNo
 population_above_18Yes
 population_adultNo
 population_elderlyYes
 gender_female1
 gender_male0
 subjects_healthyNo
 subjects_patientsNo
 subjects_vulnerable_populationsYes
 subjects_women_child_bearingNo
 subjects_women_using_contraceptionYes
 subjects_pregnant_womenNo
 subjects_nursing_womenNo
 subjects_emergency_situationNo
 subjects_incapable_consentNo
 subjects_specify
 subjects_othersYes
 subjects_others_specifyExercitation perspic
 investigator1_given_nameRachel Hewitt
 investigator1_middle_nameKylynn Townsend
 investigator1_family_nameOctavia Acosta
 investigator1_qualificationDolores quae ut corrupti voluptatem in aliquip animi esse aliqua Dicta sapiente ipsam debitis impedit nobis
 investigator1_professional_addressVel aut quis in consectetur incidunt placeat sint consectetur sint dolores commodi
 investigator1_telephone+1 (618) 138-4296
 investigator1_emailbezic@mailinator.com
 organisations_transferred_Yes
 number_participantsSuscipit adipisicing
 notification\n Clinical trials are research studies conducted with human participants to evaluate the safety, effectiveness, and potential side effects of medical interventions, such as new drugs, devices, or therapies. These trials are essential for advancing medical knowledge and ensuring treatments meet rigorous standards. By following a structured approach, clinical trials provide a systematic way to assess new interventions before they are widely adopted in healthcare.\n\n The process of clinical trials typically progresses through multiple phases. Early phases focus on determining safety and optimal dosing in smaller groups, while later phases assess the efficacy and broader application of the intervention in larger populations. This phased approach ensures that each stage addresses specific scientific and medical questions, gradually building a comprehensive understanding of the intervention's impact.\n\n Ethical guidelines and scientific rigor are crucial in clinical trials to protect participants and maintain public trust. Researchers adhere to principles like informed consent and beneficence while ensuring trials are inclusive and unbiased. By bridging the gap between laboratory research and real-world medical practice, clinical trials play a critical role in improving healthcare outcomes globally.\n
 approval_date29-11-2024
 submitted1
 deleted0
 deleted_date(null)
 deactivated0
 date_submitted20-11-2024
 unsubmitted0
 initial_date_submitted(null)
 admin_stopped0
 admin_stopped_reason(null)
 approved2
 approved_reasonTest
 approved_date(null)
 final_report\n test sample\n
 implication_results\n sample\n
 quantity_imported2
 quantity_dispensed3
 quantity_destroyed4
 quantity_exported1
 balance_site2
 final_date2025-08-05
 ecitizen_invoice324265
 modified2025-08-05 08:08:23
 created2024-10-18 08:02:13
 InvestigatorContact(array)
 0(array)
 id79
 application_id121
 given_nameLinus Sexton
 middle_nameOri Hill
 family_nameJacob Mckay
 qualificationIllum doloribus soluta numquam omnis elit quibusdam non
 professional_addressAliquam fugiat qui officia veniam excepturi et nisi neque enim aliquip tempora
 telephone+1 (188) 739-1402
 emailmipaj@mailinator.com
 created2024-11-20 09:47:01
 modified2024-11-20 10:15:06
 SiteDetail(array)
 0(array)
 id94
 application_id121
 county_id(null)
 site_name
 physical_address
 contact_details
 contact_person
 site_capacity(null)
 misc(null)
 created2013-04-16 14:25:04
 modified2024-11-20 10:15:06
 County(empty)
 Sponsor(array)
 0(array)
 id32
 application_id121
 sponsorAnim obcaecati dolorem cillum qui nemo in vitae ea veritatis
 sponsor_typeIndustry
 contact_personFugiat corporis inventore non commodo nesciunt ut non doloremque optio voluptates minima recusandae Veritatis reprehenderit velit commodo
 addressAutem odio eaque quia est blanditiis reiciendis commodi et adipisicing enim voluptate
 telephone_number+1 (343) 625-7251
 fax_number+1 (936) 324-2944
 cell_number+1 (942) 698-1737
 email_addressvugit@mailinator.com
 created2024-11-20 09:47:01
 modified2024-11-20 10:15:06
 3(array)
 Application(array)
 id124
 user_id26
 application_id(null)
 is_child0
 trial_status_id4
 total_sites2
 abstract_of_study\n Testronimal Study Phase 2\n
 study_title\n Testronimal Study Phase 2\n
 laymans_summary\n Layman SUmmary\n
 short_titleTestronimal Study Phase 2
 protocol_noECCT/24/11/01
 reference_no
 version_no1
 date_of_protocol12-11-2024
 study_drugTestronimal
 disease_conditionCancer
 product_type_biologicals1
 product_type_proteins0
 product_type_immunologicals1
 product_type_vaccines0
 product_type_hormones0
 product_type_toxoid0
 product_type_chemical1
 product_type_medical_device0
 product_type_chemical_nameEndo
 product_type_medical_device_name
 comparatorNo
 comparator_name
 comparator_registered
 comparator_countries
 ecct_not_applicable0
 ecct_ref_number
 email_addressjayoma@intellisoftkenya.com
 applicant_covering_letter1
 applicant_protocol1
 applicant_patient_information1
 applicant_investigators_brochure1
 applicant_investigators_cv1
 applicant_signed_declaration1
 applicant_financial_declaration1
 applicant_gmp_certificate1
 applicant_indemnity_cover1
 applicant_opinion_letter1
 applicant_approval_letter1
 applicant_statement1
 applicant_participating_countries(null)
 applicant_addendum1
 applicant_fees1
 applicant_complete_form(null)
 applicant_impd1
 applicant_prev_data1
 applicant_stability_data1
 applicant_analysis_cert1
 applicant_pictorial_sample1
 applicant_gcp_training1
 applicant_dsmb_charter1
 applicant_detailed_budget1
 applicant_indemnity_pi1
 applicant_practice_license1
 applicant_registration_ctr(null)
 applicant_pan_african1
 applicant_hard_copies(null)
 applicant_signed_checklist1
 statistical_analysis_plan1
 applicant_contractual_agreement1
 declaration_applicanttest
 declaration_date120-11-2024
 declaration_principal_investigatortest
 declaration_date220-11-2024
 placebo_presentNo
 study_objectives\n test\n
 principal_inclusion_criteria\n test\n
 principal_exclusion_criteria\n test\n
 primary_end_points\n test\n
 scope_diagnosis0
 scope_prophylaxis0
 scope_therapy1
 scope_safety0
 scope_efficacy0
 scope_pharmacokinetic0
 scope_pharmacodynamic0
 scope_bioequivalence0
 scope_dose_response0
 scope_pharmacogenetic1
 scope_pharmacogenomic0
 scope_pharmacoecomomic0
 scope_others0
 scope_others_specify
 trial_human_pharmacology1
 trial_administration_humans0
 trial_bioequivalence_study1
 trial_other0
 trial_other_specify
 trial_therapeutic_exploratory0
 trial_therapeutic_confirmatory1
 trial_therapeutic_use0
 design_controlledNo
 site_capacity(null)
 staff_numbers\n test\n
 other_details_explanation\n test\n
 other_details_regulatory_notapproved\n test\n
 other_details_regulatory_approved\n test\n
 other_details_regulatory_rejected\n test\n
 other_details_regulatory_halted\n test\n
 estimated_duration1year
 design_controlled_randomised
 design_controlled_open
 design_controlled_single_blind
 design_controlled_double_blind
 design_controlled_parallel_group
 design_controlled_cross_over
 design_controlled_other
 design_controlled_specify
 design_controlled_comparator
 design_controlled_other_medicinal
 design_controlled_placebo
 design_controlled_medicinal_other
 design_controlled_medicinal_specify
 single_site_member_stateNo
 location_of_area
 single_site_physical_address
 single_site_contact_person
 single_site_telephone
 multiple_sites_member_stateNo
 multiple_countriesYes
 multiple_member_states5
 number_of_sites
 multi_country_listtest
 data_monitoring_committeeYes
 total_enrolment_per_site2000
 total_participants_worldwide2000000
 population_less_than_18_yearsNo
 population_uteroNo
 population_preterm_newbornNo
 population_newbornNo
 population_infant_and_toddlerNo
 population_childrenNo
 population_adolescentNo
 population_above_18Yes
 population_adultYes
 population_elderlyNo
 gender_female1
 gender_male0
 subjects_healthyYes
 subjects_patientsNo
 subjects_vulnerable_populationsNo
 subjects_women_child_bearingNo
 subjects_women_using_contraceptionNo
 subjects_pregnant_womenNo
 subjects_nursing_womenNo
 subjects_emergency_situationNo
 subjects_incapable_consentNo
 subjects_specify
 subjects_othersNo
 subjects_others_specify
 investigator1_given_nameInvestigating
 investigator1_middle_name
 investigator1_family_name Pharmacist
 investigator1_qualificationMasters
 investigator1_professional_address67
 investigator1_telephone+254792837631
 investigator1_emailinvest@gmail.com
 organisations_transferred_No
 number_participants100000
 notification\n test\n
 approval_date21-11-2024
 submitted1
 deleted0
 deleted_date(null)
 deactivated0
 date_submitted20-11-2024
 unsubmitted1
 initial_date_submitted20-11-2024
 admin_stopped1
 admin_stopped_reasontest
 approved2
 approved_reasontest
 approved_date(null)
 final_report(null)
 implication_results(null)
 quantity_imported(null)
 quantity_dispensed(null)
 quantity_destroyed(null)
 quantity_exported(null)
 balance_site(null)
 final_date(null)
 ecitizen_invoice330895
 modified2025-01-14 12:41:33
 created2024-11-20 09:09:12
 InvestigatorContact(array)
 0(array)
 id78
 application_id124
 given_nameJoel
 middle_name
 family_nameInvestigator
 qualificationMasters
 professional_addressP.O Box 381-3558,Accra
 telephone+254790129837
 emailjayoma@intellisoftkenya.com
 created2024-11-20 09:12:27
 modified2025-01-14 12:21:23
 SiteDetail(array)
 0(array)
 id96
 application_id124
 county_id42
 site_name
 physical_address
 contact_details
 contact_person
 site_capacity(null)
 misc(null)
 created2013-04-17 09:41:35
 modified2025-01-14 12:21:23
 County(array)
 id42
 county_nameKisumu
 created2012-06-15 10:27:02
 modified2012-06-15 10:27:02
 Sponsor(array)
 0(array)
 id31
 application_id124
 sponsorSponsor
 sponsor_typeIndustry
 contact_person
 addressAddress
 telephone_number+254782930397
 fax_number
 cell_number+254782930397
 email_addressslow@gmail.com
 created2024-11-20 09:12:27
 modified2025-01-14 12:21:23
 4(array)
 Application(array)
 id120
 user_id82
 application_id(null)
 is_child0
 trial_status_id(null)
 total_sites1
 abstract_of_study\n studyabstract\n
 study_title\n abstract 123\n
 laymans_summary\n layman\n
 short_titleuser
 protocol_noECCT/24/10/02
 reference_no(null)
 version_no2
 date_of_protocol09-10-2024
 study_drugstudydrug
 disease_conditionmalaria
 product_type_biologicals1
 product_type_proteins1
 product_type_immunologicals0
 product_type_vaccines0
 product_type_hormones0
 product_type_toxoid0
 product_type_chemical0
 product_type_medical_device0
 product_type_chemical_name
 product_type_medical_device_name
 comparatorNo
 comparator_name
 comparator_registered
 comparator_countries
 ecct_not_applicable0
 ecct_ref_number
 email_addresslchepkwony@intellisoftkenya.com
 applicant_covering_letter1
 applicant_protocol1
 applicant_patient_information1
 applicant_investigators_brochure1
 applicant_investigators_cv1
 applicant_signed_declaration1
 applicant_financial_declaration1
 applicant_gmp_certificate1
 applicant_indemnity_cover1
 applicant_opinion_letter1
 applicant_approval_letter1
 applicant_statement1
 applicant_participating_countries(null)
 applicant_addendum1
 applicant_fees1
 applicant_complete_form(null)
 applicant_impd1
 applicant_prev_data1
 applicant_stability_data1
 applicant_analysis_cert1
 applicant_pictorial_sample1
 applicant_gcp_training1
 applicant_dsmb_charter1
 applicant_detailed_budget1
 applicant_indemnity_pi1
 applicant_practice_license1
 applicant_registration_ctr(null)
 applicant_pan_african1
 applicant_hard_copies(null)
 applicant_signed_checklist1
 statistical_analysis_plan1
 applicant_contractual_agreement1
 declaration_applicantDeleniti et autem ea omnis
 declaration_date104-05-2023
 declaration_principal_investigatorQuaerat aspernatur consequatur non voluptas inventore ad officiis do consequatur voluptates enim asperiores minim illum
 declaration_date218-01-2014
 placebo_presentYes
 study_objectives\n objective\n
 principal_inclusion_criteria\n inclusion\n
 principal_exclusion_criteria\n exclusion\n
 primary_end_points\n end point\n
 scope_diagnosis1
 scope_prophylaxis1
 scope_therapy0
 scope_safety1
 scope_efficacy0
 scope_pharmacokinetic0
 scope_pharmacodynamic0
 scope_bioequivalence1
 scope_dose_response0
 scope_pharmacogenetic0
 scope_pharmacogenomic0
 scope_pharmacoecomomic1
 scope_others1
 scope_others_specifySit ut lorem ut vel
 trial_human_pharmacology1
 trial_administration_humans0
 trial_bioequivalence_study1
 trial_other0
 trial_other_specify
 trial_therapeutic_exploratory0
 trial_therapeutic_confirmatory0
 trial_therapeutic_use1
 design_controlledYes
 site_capacity(null)
 staff_numbers\n 1234\n
 other_details_explanation\n explained\n
 other_details_regulatory_notapproved\n reg\n
 other_details_regulatory_approved\n reg\n
 other_details_regulatory_rejected\n reg\n
 other_details_regulatory_halted
 estimated_durationEsse ducimus possimus aut architecto esse in dolor illum tempor cillum
 design_controlled_randomisedNo
 design_controlled_openNo
 design_controlled_single_blindNo
 design_controlled_double_blindNo
 design_controlled_parallel_groupNo
 design_controlled_cross_overNo
 design_controlled_otherYes
 design_controlled_specifyNeque deserunt nostrud minima aut sed enim veniam odit assumenda officia
 design_controlled_comparatorRepellendus Sed temporib
 design_controlled_other_medicinalYes
 design_controlled_placeboYes
 design_controlled_medicinal_otherNo
 design_controlled_medicinal_specify
 single_site_member_stateNo
 location_of_area
 single_site_physical_address
 single_site_contact_person
 single_site_telephone
 multiple_sites_member_stateYes
 multiple_countriesYes
 multiple_member_states772
 number_of_sites961
 multi_country_listDelectus suscipit e
 data_monitoring_committeeNo
 total_enrolment_per_siteDolor sint animi er
 total_participants_worldwideCorrupti laudantium similique cupiditate nostrum rerum est vero laborum adipisicing
 population_less_than_18_yearsYes
 population_uteroNo
 population_preterm_newbornNo
 population_newbornYes
 population_infant_and_toddlerNo
 population_childrenNo
 population_adolescentYes
 population_above_18Yes
 population_adultYes
 population_elderlyNo
 gender_female1
 gender_male0
 subjects_healthyNo
 subjects_patientsNo
 subjects_vulnerable_populationsYes
 subjects_women_child_bearingNo
 subjects_women_using_contraceptionYes
 subjects_pregnant_womenNo
 subjects_nursing_womenYes
 subjects_emergency_situationYes
 subjects_incapable_consentYes
 subjects_specifyVoluptatum perspicia
 subjects_othersNo
 subjects_others_specify
 investigator1_given_nameBrent Mcknight
 investigator1_middle_nameNicole Gross
 investigator1_family_nameCharles Crane
 investigator1_qualificationId adipisci commodo repellendus Dolor enim iste et quam deserunt id ut ullamco
 investigator1_professional_addressQuia eius aut adipisicing rerum aut ad tempora necessitatibus cumque nisi at
 investigator1_telephone+1 (795) 542-5315
 investigator1_emaildudahabewy@mailinator.com
 organisations_transferred_No
 number_participantsVoluptatem ut nisi e
 notification
 approval_date19-11-2024
 submitted1
 deleted0
 deleted_date(null)
 deactivated0
 date_submitted23-10-2024
 unsubmitted0
 initial_date_submitted(null)
 admin_stopped0
 admin_stopped_reason(null)
 approved2
 approved_reasonApproved Here successfully
 approved_date(null)
 final_report(null)
 implication_results(null)
 quantity_imported(null)
 quantity_dispensed(null)
 quantity_destroyed(null)
 quantity_exported(null)
 balance_site(null)
 final_date(null)
 ecitizen_invoice324112
 modified2024-11-19 16:25:21
 created2024-10-17 12:04:18
 InvestigatorContact(array)
 0(array)
 id72
 application_id120
 given_nameIrene Peterson
 middle_nameMelinda Farrell
 family_nameMarah Bush
 qualificationId ipsa qui obcaecati sit iste eu reiciendis pariatur Possimus temporibus consequatur et culpa ad tenetur iusto inventore nihil labore
 professional_addressCorporis ut quo libero ut ullam error
 telephone+1 (524) 915-1935
 emailpypamyhezu@mailinator.com
 created2024-10-17 12:49:37
 modified2024-10-23 15:04:34
 SiteDetail(array)
 0(array)
 id1704
 application_id120
 county_id20
 site_nameHarriet Battle
 physical_addressQuae nulla sunt culpa beatae fugiat dolor quae labore similique in quae dignissimos a tempore ut tempore
 contact_detailsP.O. Box 5325
 contact_personNisi eum dolorem fugiat ullam dolore nemo laudantium aut autem natus similique numquam deserunt omnis quod officia
 site_capacity(null)
 misc(null)
 created2024-10-17 12:49:37
 modified2024-10-23 15:04:34
 County(array)
 id20
 county_nameKirinyaga
 created2012-06-15 10:24:22
 modified2012-06-15 10:24:22
 Sponsor(array)
 0(array)
 id29
 application_id120
 sponsorFuga Aut qui est consequatur consectetur dolorem qui blanditiis saepe natus maiores ea repellendus Velit quia ullamco
 sponsor_typeResearch Institution
 contact_personNon corrupti reiciendis placeat elit aut voluptatibus optio labore excepteur
 addressConsectetur ut ipsum quia quos magni
 telephone_number+1 (367) 517-6326
 fax_number+1 (961) 772-5694
 cell_number+1 (895) 885-1686
 email_addressrimumaxy@mailinator.com
 created2024-10-17 12:49:37
 modified2024-10-23 15:04:34
- page_options(array)
 55
 1010
- redir
- $request->data(array)
 Application(empty)
- $this->validationErrors(array)
 Permission(empty)
 Aro(empty)
 Aco(empty)
 Application(empty)
 User(empty)
 TrialStatus(empty)
 InvestigatorContact(empty)
 Sponsor(empty)
 SiteDetail(empty)
 County(empty)
- Loaded Helpers(array)
 0Html
 1Form
 2Session
 3Text
 4Number
 5SimpleGraph
 6Paginator
 7DebugTimer
 8Toolbar
 9HtmlToolbar
====

Environment

App Constants

Constant	Value
MEDIA	'/var/www/ctr/app/webroot/media/'
MEDIA_STATIC	'/var/www/ctr/app/webroot/media/static/'
MEDIA_FILTER	'/var/www/ctr/app/webroot/media/filter/'
MEDIA_TRANSFER	'/var/www/ctr/app/webroot/media/transfer/'
MEDIA_URL	'media/'
MEDIA_STATIC_URL	'media/static/'
MEDIA_FILTER_URL	'media/filter/'
MEDIA_TRANSFER_URL	'media/transfer/'
HTTP_HOST	'45.79.161.190:8080'
HTTP_BASE	'http://45.79.161.190:8080'
HTTP_SELF	'/app/webroot/index.php'
HTTP_URI	'/applications/index/sort:protocol_no/direction:desc/page:2'
CHOWN_PUBLIC	(int) 504
LF	''
NL	''
CR	''
TB	''
BR	' '
WINDOWS	false
FORMAT_DB_DATETIME	'Y-m-d H:i:s'
FORMAT_DB_DATE	'Y-m-d'
FORMAT_DB_TIME	'H:i:s'
DEFAULT_DATETIME	'0000-00-00 00:00:00'
DEFAULT_DATE	'0000-00-00'
DEFAULT_TIME	'00:00:00'
FILES	'/var/www/ctr/app/files/'
LOCALE	'/var/www/ctr/app/locale/'
CLASS_USER	'User'
VALID_ALPHA	'/^[a-zA-Z]+$/'
VALID_ALPHA_UNDERSCORES	'/^[a-zA-Z_]+$/'
VALID_ALPHA_MINUS_UNDERSCORES	'/^[a-zA-Z_-]+$/'
VALID_ALPHA_WHITESPACES	'/^[a-zA-Z ]+$/'
VALID_ALPHANUMERIC_UNDERSCORES	'/^[\da-zA-Z_]+$/'
VALID_ALPHANUMERIC_MINUS_UNDERSCORES	'/^[\da-zA-Z_-]+$/'
VALID_ALPHANUMERIC_WHITESPACES	'/^[\da-zA-Z ]+$/'
VALID_ALPHANUMERIC_WHITESPACES_UNDERSCORES	'/^[\da-zA-Z _]+$/'
VALID_NUMERIC_UNDERSCORES	'/^[\d_]+$/'
VALID_NUMERIC_WHITESPACES	'/^[\d ]+$/'
VALID_NUMERIC_WHITESPACES_UNDERSCORES	'/^[\d _]+$/'
VALID_INTEGERS	'/^[\d]+$/'
FORMAT_NICE_YMDHMS	'd.m.Y, H:i:s'
FORMAT_NICE_YMDHM	'd.m.Y, H:i'
FORMAT_NICE_YM	'm.Y'
FORMAT_NICE_YMD	'd.m.Y'
FORMAT_NICE_MD	'd.m.'
FORMAT_NICE_D	'd'
FORMAT_NICE_W_NUM	'w'
FORMAT_NICE_W_ABBR	'D'
FORMAT_NICE_W_FULL	'l'
FORMAT_NICE_M	'm'
FORMAT_NICE_M_ABBR	'M'
FORMAT_NICE_M_FULL	'F'
FORMAT_NICE_Y_ABBR	'y'
FORMAT_NICE_Y	'Y'
FORMAT_NICE_HM	'H:i'
FORMAT_NICE_HMS	'H:i:s'
FORMAT_LOCAL_WA_YMDHMS	'%a, %d.%m.%Y, %H:%M:%S'
FORMAT_LOCAL_WF_YMDHMS	'%A, %d.%m.%Y, %H:%M:%S'
FORMAT_LOCAL_WA_YMDHM	'%a, %d.%m.%Y, %H:%M'
FORMAT_LOCAL_WF_YMDHM	'%A, %d.%m.%Y, %H:%M'
FORMAT_LOCAL_YMDHMS	'%d.%m.%Y, %H:%M:%S'
FORMAT_LOCAL_YMDHM	'%d.%m.%Y, %H:%M'
FORMAT_LOCAL_YMD	'%d.%m.%Y'
FORMAT_LOCAL_MD	'%d.%m.'
FORMAT_LOCAL_D	'%d'
FORMAT_LOCAL_W_NUM	'%w'
FORMAT_LOCAL_W_ABBR	'%a'
FORMAT_LOCAL_W_FULL	'%A'
FORMAT_LOCAL_M	'%m'
FORMAT_LOCAL_M_ABBR	'%b'
FORMAT_LOCAL_M_FULL	'%B'
FORMAT_LOCAL_Y_ABBR	'%y'
FORMAT_LOCAL_YMS_ABBR	'%d.%m.%y'
FORMAT_LOCAL_Y	'%Y'
FORMAT_LOCAL_H	'%H'
FORMAT_LOCAL_S	'%S'
FORMAT_LOCAL_HM	'%H:%M'
FORMAT_LOCAL_HMS	'%H:%M:%S'
CHAR_LESS	'<'
CHAR_GREATER	'>'
CHAR_QUOTE	'"'
CHAR_APOSTROPHE	'''
CHAR_ARROWS	'»'
CHAR_ARROWS_R	'»'
CHAR_ARROWS_L	'«'
CHAR_AVERAGE	'Ø'
CHAR_INFIN	'∞'
CHAR_MILL	'‰'
CHAR_PLUSMN	'±'
CHAR_HELLIP	'…'
CHAR_CIRCA	'≈'
CHAR_CHECKBOX_EMPTY	'☐]'
CHAR_CHECKBOX_MAKRED	'☑'
CHAR_CHECKMARK	'✓'
CHAR_CHECKMARK_BOLD	'✔'
CHAR_BALLOT	'✗'
CHAR_BALLOT_BOLD	'✘'
CHAR_ABOUT	'≈'
CHAR_RPIME	'′'
CHAR_DOUBLE_RPIME	'″'

CakePHP Constants

Constant	Value
APP	'/var/www/ctr/app/'
APP_DIR	'app'
APPLIBS	'/var/www/ctr/app/Lib/'
CACHE	'/var/www/ctr/app/tmp/cache/'
CAKE	'/var/www/ctr/lib/Cake/'
CAKE_CORE_INCLUDE_PATH	'/var/www/ctr/lib'
CORE_PATH	'/var/www/ctr/lib/'
CAKE_VERSION	'2.2.2'
CSS	'/var/www/ctr/app/webroot/css/'
CSS_URL	'css/'
DS	'/'
FULL_BASE_URL	'http://45.79.161.190:8080'
IMAGES	'/var/www/ctr/app/webroot/img/'
IMAGES_URL	'img/'
JS	'/var/www/ctr/app/webroot/js/'
JS_URL	'js/'
LOGS	'/var/www/ctr/app/tmp/logs/'
ROOT	'/var/www/ctr'
TESTS	'/var/www/ctr/app/Test/'
TMP	'/var/www/ctr/app/tmp/'
VENDORS	'/var/www/ctr/vendors/'
WEBROOT_DIR	'webroot'
WWW_ROOT	'/var/www/ctr/app/webroot/'

PHP Environment

Environment Variable	Value
Php Version	'5.6.40-63+ubuntu18.04.1+deb.sury.org+2'
Redirect Redirect Status	'200'
Redirect Status	'200'
Http Accept	'/'
Http User Agent	'Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)'
Http Cookie	'CAKEPHP=ore0ssccvida4ers12okbf93u4'
Http Accept Encoding	'gzip, br, zstd, deflate'
Http Host	'45.79.161.190:8080'
Http Via	'1.1 squid-proxy-5b5d847c96-qq957 (squid/6.10)'
Http X Forwarded For	'10.3.82.253'
Http Cache Control	'max-age=259200'
Http Connection	'keep-alive'
Path	'/usr/local/sbin:/usr/local/bin:/usr/sbin:/usr/bin:/sbin:/bin:/snap/bin'
Server Signature	' Apache/2.4.29 (Ubuntu) Server at 45.79.161.190 Port 8080 '
Server Software	'Apache/2.4.29 (Ubuntu)'
Server Name	'45.79.161.190'
Server Addr	'45.79.161.190'
Server Port	'8080'
Remote Addr	'216.73.216.36'
Document Root	'/var/www/ctr'
Request Scheme	'http'
Context Prefix	''
Context Document Root	'/var/www/ctr'
Server Admin	'webmaster@localhost'
Script Filename	'/var/www/ctr/app/webroot/index.php'
Remote Port	'47175'
Redirect Url	'/app/webroot/applications/index/sort:protocol_no/direction:desc/page:2'
Gateway Interface	'CGI/1.1'
Server Protocol	'HTTP/1.1'
Request Method	'GET'
Query String	''
Request Uri	'/applications/index/sort:protocol_no/direction:desc/page:2'
Script Name	'/app/webroot/index.php'
Php Self	'/app/webroot/index.php'
Request Time Float	(float) 1756477054.166
Request Time	(int) 1756477054

====

Include
+
Included Files

Include Paths
- 0/var/www/ctr/app/Plugin/Media/Lib/mm/src
- 1/var/www/ctr/lib
- 3/usr/share/php
- 4-> /var/www/ctr/lib/Cake/
Included Files
- core(array)
  Behavior(array)
  0CORE/Model/Behavior/TreeBehavior.php
  1CORE/Model/Behavior/ContainableBehavior.php
  2CORE/Model/Behavior/AclBehavior.php
  Cache(array)
  0CORE/Cache/Cache.php
  1CORE/Cache/Engine/FileEngine.php
  2CORE/Cache/CacheEngine.php
  Component(array)
  0CORE/Controller/Component/AclComponent.php
  1CORE/Controller/Component/Acl/DbAcl.php
  2CORE/Controller/Component/Acl/AclInterface.php
  3CORE/Controller/Component/AuthComponent.php
  4CORE/Controller/Component/RequestHandlerComponent.php
  5CORE/Controller/Component/SessionComponent.php
  6CORE/Controller/Component/PaginatorComponent.php
  Config(array)
  0CORE/Config/routes.php
  1CORE/Config/config.php
  Controller(array)
  0CORE/Controller/Controller.php
  1CORE/Controller/ComponentCollection.php
  2CORE/Controller/Component.php
  Datasource(array)
  0CORE/Model/Datasource/CakeSession.php
  1CORE/Model/Datasource/Database/Mysql.php
  2CORE/Model/Datasource/DboSource.php
  3CORE/Model/Datasource/DataSource.php
  Error(array)
  0CORE/Error/exceptions.php
  1CORE/Error/ErrorHandler.php
  I18n(array)
  0CORE/I18n/I18n.php
  1CORE/I18n/L10n.php
  Log(array)
  0CORE/Log/CakeLog.php
  1CORE/Log/LogEngineCollection.php
  2CORE/Log/Engine/FileLog.php
  3CORE/Log/Engine/BaseLog.php
  4CORE/Log/CakeLogInterface.php
  Model(array)
  0CORE/Model/ConnectionManager.php
  1CORE/Model/Permission.php
  2CORE/Model/Model.php
  3CORE/Model/BehaviorCollection.php
  4CORE/Model/Aro.php
  5CORE/Model/AclNode.php
  6CORE/Model/Aco.php
  7CORE/Model/ModelBehavior.php
  Network(array)
  0CORE/Network/CakeRequest.php
  1CORE/Network/CakeResponse.php
  Other(array)
  0CORE/bootstrap.php
  1CORE/basics.php
  2CORE/Core/App.php
  3CORE/Core/Configure.php
  4CORE/Core/CakePlugin.php
  5CORE/Event/CakeEventListener.php
  6CORE/Event/CakeEvent.php
  7CORE/Event/CakeEventManager.php
  8CORE/Core/Object.php
  Routing(array)
  0CORE/Routing/Dispatcher.php
  1CORE/Routing/Filter/AssetDispatcher.php
  2CORE/Routing/DispatcherFilter.php
  3CORE/Routing/Filter/CacheDispatcher.php
  4CORE/Routing/Router.php
  5CORE/Routing/Route/CakeRoute.php
  6CORE/Routing/Route/PluginShortRoute.php
  Utility(array)
  0CORE/Utility/Hash.php
  1CORE/Utility/Inflector.php
  2CORE/Utility/ObjectCollection.php
  3CORE/Utility/Debugger.php
  4CORE/Utility/String.php
  5CORE/Utility/ClassRegistry.php
  6CORE/Utility/Set.php
  7CORE/Utility/Sanitize.php
  View(array)
  0CORE/View/HelperCollection.php
- app(array)
  Behavior(array)
  0APP/Model/Behavior/SoftDeleteBehavior.php
  Config(array)
  0APP/Config/core.php
  1APP/Config/bootstrap.php
  2APP/Config/routes.php
  3APP/Config/database.php
  Controller(array)
  0APP/Controller/ApplicationsController.php
  1APP/Controller/AppController.php
  Model(array)
  0APP/Model/AppModel.php
  1APP/Model/Application.php
  2APP/Model/User.php
  3APP/Model/TrialStatus.php
  4APP/Model/InvestigatorContact.php
  5APP/Model/Sponsor.php
  6APP/Model/SiteDetail.php
  7APP/Model/County.php
  Other(array)
  0APP/webroot/index.php
- plugins(array)
  CakePdf(array)
  Config(array)
  0CakePdf/Config/bootstrap.php
  1CakePdf/Config/routes.php
  CakeResque(array)
  Config(array)
  0CakeResque/Config/bootstrap.php
  Plugin(array)
  0CakeResque/Lib/CakeResque.php
  1CakeResque/vendor/kamisama/php-resque-ex/lib/Resque.php
  2CakeResque/vendor/kamisama/php-resque-ex/lib/Resque/Event.php
  3CakeResque/vendor/kamisama/php-resque-ex/lib/Resque/Exception.php
  DebugKit(array)
  Component(array)
  0DebugKit/Controller/Component/ToolbarComponent.php
  Plugin(array)
  0DebugKit/Lib/DebugMemory.php
  1DebugKit/Lib/Panel/HistoryPanel.php
  2DebugKit/Lib/DebugPanel.php
  3DebugKit/Lib/Panel/SessionPanel.php
  4DebugKit/Lib/Panel/RequestPanel.php
  5DebugKit/Lib/Panel/SqlLogPanel.php
  6DebugKit/Lib/Panel/TimerPanel.php
  7DebugKit/Lib/Panel/LogPanel.php
  8DebugKit/Lib/Log/Engine/DebugKitLog.php
  9DebugKit/Lib/Panel/VariablesPanel.php
  10DebugKit/Lib/Panel/EnvironmentPanel.php
  11DebugKit/Lib/Panel/IncludePanel.php
  12DebugKit/Lib/DebugTimer.php
  Media(array)
  Config(array)
  0Media/Config/bootstrap.php
  Plugin(array)
  0Media/Lib/mm/src/Mime/Type.php
  1Media/Lib/mm/src/Mime/Type/Magic/Adapter/Fileinfo.php
  2Media/Lib/mm/src/Mime/Type/Magic/Adapter.php
  3Media/Lib/mm/src/Mime/Type/Glob/Adapter/Memory.php
  4Media/Lib/mm/src/Mime/Type/Glob/Adapter.php
  5Media/Lib/mm/src/Media/Process.php
  6Media/Lib/mm/src/Media/Info.php
  Search(array)
  Component(array)
  0Search/Controller/Component/PrgComponent.php
  Behavior(array)
  0Search/Model/Behavior/SearchableBehavior.php
  Shim(array)
  Config(array)
  0Shim/Config/bootstrap.php
  Tools(array)
  Config(array)
  0Tools/Config/bootstrap.php
====

Clinical Trial Applications: Filter, Search, and view applications {lang: 'en-GB'}

Request History

Session

Request

Cake Params

Post data

Query string

Cookie

Current Route

Sql Logs

default

Total Time: 3 ms Total Queries: 10 queries

Query Explain:

Memory

Timers

Logs

View Variables

App Constants

CakePHP Constants

PHP Environment

Included Files

Include Paths

Included Files

Clinical Trial Applications: Filter, Search, and view applications

Total Time: 3 ms
Total Queries: 10 queries